News-Papers
Testimonial
Video Gallery
Retinoids for chemoprophylaxis of nonmelanoma skin cancer
Published on Monday, 09 March 2015
Retinoids for chemoprophylaxis of nonmelanoma skin cancer
See also All-Trans-Retinoic Acid (ATRA - analogues and/or derivatives).
Search
Follow us...
Latest
- MELATONIN AND COLORECTAL CANCER: THE RISE OF STANDARD TREATMENT EFFICACY
- MELATONIN ENHANCES TEMOZOLOMIDE-INDUCED APOPTOSIS IN GLIOBLASTOMA AND NEUROBLASTOMA CELLS
- Melatonin Induces AGS Gastric Cancer Cell Apoptosis via Regulating PERK/eIF2α and HSF1/NF-κB Signaling Pathway
- Melatonin, circadian rhythms and breast cancer
- Melatonin in dental practice: applications and prospects (literature review)
- Melatonin mitigates doxorubicin induced chemo brain in a rat model in a NRF2/p53-SIRT1 dependent pathway
- Melatonin Mitigates the Progression of Chemically Induced Hepatocellular Carcinoma in Rats via Targeting Wnt/Β-Catenin Pathway, and Small Noncoding miR-let-7b
- Melatonin - known problems and perspectives of clinical usage
- MELATONIN: POTENTIAL UTILITY FOR IMPROVING PUBLIC HEALTH
- Melatonin: A Powerful Integrative Adjunctive Agent for Oncology
- Melatonin: action as antioxidant and potential applications in human disease and aging
- Melatonin: an established antioxidant worthy of use in clinical trials
- Melatonin and cancer: From the promotion of genomic stability to use in cancer treatment
- Melatonin and Cancer Hallmarks
- Melatonin and Health: Insights of Melatonin Action, Biological Functions, and Associated Disorders
- Melatonin as a Therapeutic Agent for the Inhibition of Hypoxia-Induced Tumor Progression: A Description of Possible Mechanisms Involved
- Melatonin as an antioxidant: biochemical mechanisms and pathophysiological implications in humans
- Melatonin as antioxidant, geroprotector and anticarcinogen
Most Read
- The Di Bella Method (DBM)
- All-trans-retinoic acid and cancer
- About melatonin - 1996
- Biography
- The Di Bella Method Increases by the 30% the survival rate for Pancreas tumors and for this reason should be proposed as first line therapy for this type of cancer
- Somatostatin in oncology, the overlooked evidences
- Chronic Lymphocytic Leukemia: 4 patients, long-lasting remission
- Bibliography
- Large B-cells Non-Hodgkin's Lymphoma, Stage IV-AE: a Case Report
- How effective is chemo therapy?
- Non-Hodgkin's Lymphoma, Stage III-B-E: a Case Report
- Treatment of Low-grade Non-Hodgkin’s Lymphomas at Advanced Stage
- Vademecum
- Complete objective response to biological therapy of plurifocal breast carcinoma
- Frequently Asked Questions
- Declaration recommends eliminate the use of Impact factor for research evaluation
- Di Bella Method's improved survival, objective response and performance status in a retrospective observational clinical study on 55 cases of Lymphomas
- Non–Small-Cell Lung Cancer Patients with Low Performance Status: study on 28 patients